Medicare Enrolled
Dr. John Gumina, M.D.
Family Medicine · Freehold, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gumina from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gumina?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gumina
Dr. John Gumina is a family medicine specialist in Freehold, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gumina performed 1,619 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Gumina received a total of $11,400 from 53 pharmaceutical and/or device companies across 791 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gumina is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 16% volume in NJ
$11,400 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,619
Medicare services
Top 16% in NJ for family medicine
Not available
Unique patients (not deduplicated)
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
807 | $94 | $434 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
152 | $33 | $103 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
150 | $71 | $110 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
123 | $10 | $50 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
107 | $139 | $443 |
| Stool test for blood to screen for colon tumors A test that analyzes a stool sample to detect hidden blood, which is used to screen for colon tumors. |
59 | $4 | $18 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
57 | $60 | $308 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
41 | $38 | $165 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
37 | $9 | $29 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
22 | $59 | $234 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
21 | $3 | $11 |
| Tendon or ligament injection A procedure involving the injection of medication into a tendon or ligament. |
15 | $40 | $200 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
15 | $172 | $702 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $110 | $563 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$11,400
Total received (2018-2024)
Avg $1,629/year across 7 years
Top 3% in NJ for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
791
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,402
2023
$1,921
2022
$1,457
2021
$1,773
2020
$1,794
2019
$1,013
2018
$1,039
Payments by company (2024)
ABBVIE INC.
$368
AstraZeneca Pharmaceuticals LP
$298
Novo Nordisk Inc
$264
Lilly USA, LLC
$234
Abbott Laboratories
$194
Boehringer Ingelheim Pharmaceuticals, Inc.
$179
Bayer Healthcare Pharmaceuticals Inc.
$147
Exact Sciences Corporation
$141
Dynavax Technologies Corporation
$87
Amgen Inc.
$83
Astellas Pharma US Inc
$68
GlaxoSmithKline, LLC.
$62
PFIZER INC.
$54
Phathom Pharmaceuticals, Inc.
$45
SANOFI-AVENTIS U.S. LLC
$44
Esperion Therapeutics, Inc.
$43
Otsuka America Pharmaceutical, Inc.
$33
Corcept Therapeutics
$17
E.R. Squibb & Sons, L.L.C.
$14
Teva Pharmaceuticals USA, Inc.
$14
Mannkind Corporation
$13
Top 3 companies account for 38.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,844
Novo Nordisk Inc
$1,747
Lilly USA, LLC
$1,121
ABBVIE INC.
$960
Boehringer Ingelheim Pharmaceuticals, Inc.
$720
Amarin Pharma Inc.
$691
AbbVie Inc.
$369
PFIZER INC.
$343
Exact Sciences Corporation
$305
Amgen Inc.
$292
Abbott Laboratories
$288
Merck Sharp & Dohme Corporation
$264
Kowa Pharmaceuticals America, Inc.
$260
Bayer Healthcare Pharmaceuticals Inc.
$250
GlaxoSmithKline, LLC.
$244
Teva Pharmaceuticals USA, Inc.
$224
Allergan, Inc.
$194
SANOFI-AVENTIS U.S. LLC
$116
Dynavax Technologies Corporation
$114
Astellas Pharma US Inc
$83
Dexcom, Inc.
$74
E.R. Squibb & Sons, L.L.C.
$62
AbbVie, Inc.
$57
Esperion Therapeutics, Inc.
$55
Biohaven Pharmaceutical Holding Company Ltd.
$54
Endo Pharmaceuticals Inc.
$53
Otsuka America Pharmaceutical, Inc.
$48
Phathom Pharmaceuticals, Inc.
$45
Takeda Pharmaceuticals U.S.A., Inc.
$44
Corcept Therapeutics
$37
Sanofi Pasteur Inc.
$34
Novartis Pharmaceuticals Corporation
$33
Intuitive Surgical, Inc.
$32
SANOFI PASTEUR INC.
$29
Daiichi Sankyo Inc.
$29
Xeris Pharmaceuticals, Inc.
$27
Stryker Corporation
$27
Bayer HealthCare Pharmaceuticals Inc.
$24
Merck Sharp & Dohme LLC
$15
Bardy Diagnostics, Inc.
$15
Eisai Inc.
$15
Gebauer Company
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$14
Amneal Pharmaceuticals LLC
$14
Medtronic, Inc.
$14
Paratek Pharmaceuticals, Inc.
$14
Janssen Pharmaceuticals, Inc
$14
Sunovion Pharmaceuticals Inc.
$13
Mannkind Corporation
$13
Philips Electronics North America Corporation
$13
Seqirus USA Inc
$13
Allergan Inc.
$12
Biohaven Pharmaceuticals, Inc.
$11
Top 3 companies account for 41.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AFREZZA · AIRSUPRA · AJOVY · AMYVID · ANORO · ANORO ELLIPTA · APTIOM · AUSTEDO · Aimovig · BAQSIMI · BASAGLAR · BEXSERO · BREZTRI · BYDUREON · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CREON · Carnation Ambulatory Monitor · Cologuard Collection Kit · Creon · Da Vinci Surgical System · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · FARXIGA · FASENRA · FIASP · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fluad · FreeStyle Libre · GVOKE PFS · Heplisav-B · INJECTAFER · INTELLIS ADAPTIVESTIM · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · LYRICA · Livalo · MOUNJARO · MYRBETRIQ · NASCOBAL · NEXLETOL · NUEDEXTA · NURTEC ODT · NUZYRA · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TRUMENBA · TZIELD · Tresiba · Trintellix · UBRELVY · UNITHROID · VIBERZI · VITOSS · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XIFAXAN · Xultophy 100/3.6 · ZEPBOUND
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family medicine physicians in nearby ZIP areas
626
County median income
$122,727
Nearest hospital to ZIP centroid (approximate)
CENTRASTATE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gumina is a clinical cardiology specialist, with above-average Medicare volume (top 16% in NJ), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gumina experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gumina performed 807 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Gumina receive payments from pharmaceutical companies?
Yes. Dr. Gumina received a total of $11,400 from 53 companies across 791 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gumina's costs compare to other family medicine physicians in Freehold?
Dr. Gumina's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gumina) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Freehold
Browse family medicine physicians in Freehold ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in NJ
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in NJ
Which NJ family medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology